Memorial Sloan-Kettering Cancer Center

Scientists Uncover Function of BRCA2 Protein
13 Sep 02 | Structural biologists at Memorial Sloan-Kettering Cancer Center (MSKCC) have discovered the function of the protein BRCA2. Mutations in the BRCA2 gene have been linked to hereditary breast and ovarian cancers.

Drug Protects Fertility, Offspring in Mice after Radiation Exposure
30 Aug 02 | Scientists have discovered a drug that prevents sterility in female mice after exposure to ionizing radiation. Additional findings suggest that this is accomplished without yielding genetic damage in the offspring of the irradiated mothers.

New Computational Biology Center Will Boost Cancer Research
23 Jul 02 | With the recruitment of computational biologist Chris Sander, Memorial Sloan-Kettering Cancer Center begins a new initiative to develop computational methods in basic biology and cancer research and to obtain medical knowledge from the human genome.

Memorial Sloan-Kettering Cancer Center Opens Suffolk Outpatient Center
24 Jun 02 | Memorial Sloan-Kettering Cancer Center (MSKCC) will open its first freestanding outpatient facility today, bringing the number of its regional care sites to six.

Anne Thomas Appointed Vice President, Public Affairs
03 Jun 02 | Anne Thomas has been named Vice President, Public Affairs at Memorial Sloan-Kettering Cancer Center. Thomas will oversee a wide range of communications efforts including media relations, website design and content, publications and community affairs.

Surgery May Prevent Breast & Ovarian Cancers in Women with BRCA Mutations
22 May 02 | While it is true that detecting cancer at its earliest stages offers patients the best chance for cure, preventing it altogether is ideal. New evidence shows that surgery may be the most effective way to prevent breast and ovarian cancers.

Genetic Fingerprinting Improves Diagnosis & Treatment of Sarcoma
19 May 02 | Decades of research into the cell's molecular mechanics have produced a promising arsenal of drugs that selectively attack cancer cells and leave the surrounding normal tissue relatively untouched.

National Medal of Science Awarded to Dr. Harold Varmus
10 May 02 | Memorial Sloan-Kettering Cancer Center President Harold Varmus has been named a recipient of a 2001 National Medal of Science. The honor recognizes Dr. Varmus's service as Director of the NIH and his significant scientific accomplishments.

Racial Disparity in Cancer Survival: Are Other Factors at Work?
23 Apr 02 | If you are a white American with cancer, you have a greater chance of achieving the milestone 5-year survival than if you are black. While the numbers - 63% versus 52% - appear to speak for themselves, they mask potential causes for this disparity.

Hospital Volume & Surgical Experience Key to Prostate Cancer Outcomes
10 Apr 02 | Men diagnosed with prostate cancer often have concerns about the complications that affect their quality of life after surgery, the most common treatment for early-stage prostate cancer in which the disease has not spread beyond the prostate area.

Early Breast & Ovarian Cancers Detected in High-Risk Women
01 Mar 02 | When the BRCA1 and BRCA2 genes for breast and ovarian cancers were first identified and a screening blood test became available, the discoveries provoked a debate as to whether there was an advantage to learning one's risk.

Patricia Skarulis Named Vice President, Information Systems
04 Feb 02 | Patricia C. Skarulis has been named Vice President, Information Systems, and Chief Information Officer at the Memorial Sloan-Kettering Cancer Center (MSKCC). Ms. Skarulis oversees a 314-member staff.

Computerized Tool Predicts Sarcoma Survival
01 Feb 02 | In a development that holds promise for advancing the treatment of patients with sarcoma, researchers at Memorial Sloan-Kettering Cancer Center have developed a new prognostic tool that is more accurate than any previously available for this disease.

Combined PET/CT Scanner Improves Treatment
15 Jan 02 | Clinicians at Memorial Sloan-Kettering Cancer Center (MSKCC) are now able to view cancer in a more precise way, with the installation of two cutting-edge combined PET/CT scanners.

Improved Palliative Care for African Americans Sought
02 Jan 02 | Representatives of approximately 100 national organizations will gather in Harlem January 3rd and 4th to discuss the medical, social, and spiritual supports needed to care for seriously ill and dying patients.

Leukemia Model Created Using Human Cells
01 Jan 02 | Scientists have been able to use normal, human stem cells to model a common type of leukemia in the laboratory. A genetic mutation linked to leukemia was combined with human stem cells to create a model of acute myelogenous leukemia (AML).

New Leadership at Memorial Sloan-Kettering
26 Dec 01 | Harold Varmus, President of Memorial Sloan-Kettering Cancer Center, today announced the appointments of Robert E. Wittes as Physician-in-Chief of Memorial Hospital and Thomas J. Kelly as Chairman of the Sloan-Kettering Institute.

Molecular Structure of Cancer-Related Proteins Identified
18 Dec 01 | Research published in this week's issue of Nature describes the molecular structure of two cancer-related proteins binding to one another. Scientists identified the properties of these molecules using a process called X-ray crystallography.

Molecular Nanogenerator Can Target Cancer Cells
15 Nov 01 | Researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) have developed a molecular nanogenerator that releases a cascade of atomic fragments known as alpha particles on the inside of cancer cells.

New Generation of Leaders Honored
12 Nov 01 | Recipients of the first Paul Marks Prize for Cancer Research, a unique One Hundred and Twenty-Five Thousand Dollar award to be shared by young investigators for major accomplishments in cancer research, have been named.